A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (opens ClinicalTrials.gov)
- Sponsor
- Eli Lilly and Company
- Enrolment
- 134
- Started
- 2023-02-08
- Last update
- 2026-09-11
Conditions: Overweight, Obesity, Chronic Kidney Disease, Type 2 Diabetes…
Interventions: Tirzepatide, Placebo